Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways

Plasmablastic lymphoma (PBL) represents a clinically heterogeneous subtype of aggressive B-cell non-Hodgkin lymphoma. Targeted-sequencing studies and a single-center whole-exome sequencing (WES) study in HIV-positive patients recently revealed several genes associated with PBL pathogenesis; however,...

Descripción completa

Detalles Bibliográficos
Autores principales: Witte, Hanno M., Künstner, Axel, Hertel, Nadine, Bernd, Heinz-Wolfram, Bernard, Veronica, Stölting, Stephanie, Merz, Hartmut, von Bubnoff, Nikolas, Busch, Hauke, Feller, Alfred C., Gebauer, Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791589/
https://www.ncbi.nlm.nih.gov/pubmed/34714908
http://dx.doi.org/10.1182/bloodadvances.2021005486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791589/
https://www.ncbi.nlm.nih.gov/pubmed/34714908
http://dx.doi.org/10.1182/bloodadvances.2021005486

Ejemplares similares